{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["5-fluorouracil", "MiR-532-3p", "colorectal cancer", "liposome", "si-KRAS"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36324898", "DateRevised": {"Year": "2022", "Month": "11", "Day": "04"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "10", "Day": "17"}], "Language": ["eng"], "ELocationID": ["1013541", "10.3389/fbioe.2022.1013541"], "Journal": {"ISSN": "2296-4185", "JournalIssue": {"Volume": "10", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in bioengineering and biotechnology", "ISOAbbreviation": "Front Bioeng Biotechnol"}, "ArticleTitle": "Targeted delivery of 5-fluorouracil, miR-532-3p, and si-KRAS to the colorectal tumor using layer-by-layer liposomes.", "Pagination": {"StartPage": "1013541", "MedlinePgn": "1013541"}, "Abstract": {"AbstractText": ["Co-delivery of siRNA or miRNA with chemotherapeutic drugs into tumor sites is an attractive synergetic strategy for treating colorectal cancer (CRC) due to their complementary mechanisms. In the current work, a liposome nanoparticle (Huang et al., Cancer Metastasis Rev., 2018, 37, 173-187) coated by cationic chitosan (CS) using a controlled layer-by-layer (LbL) process was designed to deliver simultaneous si-KRAS, miRNA-532-3p, and 5-Fluorouracil (5-FU) into CRC cells. The LbL NPs exhibited a spherical structure with an average size of 165.9\u00a0nm and effectively protected si-KRAS and miRNA-532-3p against degradation by serum and nucleases. Interestingly, the LbL NPs were successfully entered into cells and efficiently promoted cytotoxicity and suppressed cancer cell migration and invasion. <i>In vivo</i>, the LbL NPs reduced tumor growth in SW480-tumor-bearing mice models. In conclusion, these results suggested that the LbL NPs co-loaded with 5-FU and miR-532-3p/si-KRAS might provide a promising potential strategy for inhibiting the malignant phenotypes of CRC cells."], "CopyrightInformation": "Copyright \u00a9 2022 Shahidi, Abazari, Dayati, Haghiralsadat, Oroojalian and Tofighi."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Biochemistry, School of Medicine, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran."}], "LastName": "Shahidi", "ForeName": "Maryamsadat", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Biochemistry, School of Medicine, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran."}], "LastName": "Abazari", "ForeName": "Omid", "Initials": "O"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran."}], "LastName": "Dayati", "ForeName": "Parisa", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Nanotechnology and Tissue Engineering Research Center, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran."}], "LastName": "Haghiralsadat", "ForeName": "Bibi Fatemeh", "Initials": "BF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Advanced Technologies, School of Medicine, North Khorasan University of Medical Sciences, Bojn\u016brd, Iran."}, {"Identifier": [], "Affiliation": "Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Oroojalian", "ForeName": "Fatemeh", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Psychology, University of New Mexico, Albuquerque, NM, United States."}], "LastName": "Tofighi", "ForeName": "Davood", "Initials": "D"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Bioeng Biotechnol", "NlmUniqueID": "101632513", "ISSNLinking": "2296-4185"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abtahi N. A., Naghib S. M., Ghalekohneh S. J., Mohammadpour Z., Nazari H., Mosavi S. M., et al. (2022). Multifunctional stimuli-responsive niosomal nanoparticles for co-delivery and co-administration of gene and bioactive compound: In vitro and in vivo studies. Chem. Eng. J. 429, 132090. 10.1016/j.cej.2021.132090", "ArticleIdList": ["10.1016/j.cej.2021.132090"]}, {"Citation": "Blondy S., David V., Verdier M., Mathonnet M., Perraud A., Christou N. (2020). 5\u2010Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes. Cancer Sci. 111, 3142\u20133154. 10.1111/cas.14532", "ArticleIdList": ["10.1111/cas.14532", "PMC7469786", "32536012"]}, {"Citation": "Boyiddle C., Ruboyianes M., Del Valle E., Bubendorf L., Trunzer K., Pugh J., et al. (2017). Development of IHC staining protocols for assessment of PD-L1 expression in cytological samples. United States: AACR."}, {"Citation": "Chen Y., Gao D.-Y., Huang L. (2015). In vivo delivery of miRNAs for cancer therapy: challenges and strategies. Adv. drug Deliv. Rev. 81, 128\u2013141. 10.1016/j.addr.2014.05.009", "ArticleIdList": ["10.1016/j.addr.2014.05.009", "PMC5009470", "24859533"]}, {"Citation": "Danaei M., Dehghankhold M., Ataei S., Hasanzadeh Davarani F., Javanmard R., Dokhani A., et al. (2018). Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics 10, 57. 10.3390/pharmaceutics10020057", "ArticleIdList": ["10.3390/pharmaceutics10020057", "PMC6027495", "29783687"]}, {"Citation": "Duan X., Li Y. (2013). Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking. Small 9, 1521\u20131532. 10.1002/smll.201201390", "ArticleIdList": ["10.1002/smll.201201390", "23019091"]}, {"Citation": "Eygeris Y., Patel S., Jozic A., Sahay G. (2020). Deconvoluting lipid nanoparticle structure for messenger RNA delivery. Nano Lett. 20, 4543\u20134549. 10.1021/acs.nanolett.0c01386", "ArticleIdList": ["10.1021/acs.nanolett.0c01386", "PMC7228479", "32375002"]}, {"Citation": "Gu L., Deng Z. J., Roy S., Hammond P. T. (2017). A combination RNAi-chemotherapy layer-by-layer nanoparticle for systemic targeting of KRAS/P53 with cisplatin to treat non\u2013small cell lung cancer. Clin. Cancer Res. 23, 7312\u20137323. 10.1158/1078-0432.ccr-16-2186", "ArticleIdList": ["10.1158/1078-0432.ccr-16-2186", "PMC5712246", "28912139"]}, {"Citation": "Gu C., Cai J., Xu Z., Zhou S., Ye L., Yan Q., et al. (2019). MiR-532-3p suppresses colorectal cancer progression by disrupting the ETS1/TGM2 axis-mediated Wnt/\u03b2-catenin signaling. Cell Death Dis. 10, 739\u2013814. 10.1038/s41419-019-1962-x", "ArticleIdList": ["10.1038/s41419-019-1962-x", "PMC6768886", "31570702"]}, {"Citation": "Gupta B., Ruttala H. B., Poudel B. K., Pathak S., Regmi S., Gautam M., et al. (2018). Polyamino acid layer-by-layer (LbL) constructed silica-supported mesoporous titania nanocarriers for stimuli-responsive delivery of microRNA 708 and paclitaxel for combined chemotherapy. ACS Appl. Mat. Interfaces 10, 24392\u201324405. 10.1021/acsami.8b06642", "ArticleIdList": ["10.1021/acsami.8b06642", "29978708"]}, {"Citation": "Huang D., Sun W., Zhou Y., Li P., Chen F., Chen H., et al. (2018). Mutations of key driver genes in colorectal cancer progression and metastasis. Cancer Metastasis Rev. 37, 173\u2013187. 10.1007/s10555-017-9726-5", "ArticleIdList": ["10.1007/s10555-017-9726-5", "29322354"]}, {"Citation": "Keum N., Giovannucci E. (2019). Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat. Rev. Gastroenterol. Hepatol. 16, 713\u2013732. 10.1038/s41575-019-0189-8", "ArticleIdList": ["10.1038/s41575-019-0189-8", "31455888"]}, {"Citation": "Lam J. K., Chow M. Y., Zhang Y., Leung S. W. (2015). siRNA versus miRNA as therapeutics for gene silencing. Mol. Ther. - Nucleic Acids 4, e252. 10.1038/mtna.2015.23", "ArticleIdList": ["10.1038/mtna.2015.23", "PMC4877448", "26372022"]}, {"Citation": "Lollo G., Matha K., Bocchiardo M., Bejaud J., Marigo I., Virgone-Carlotta A., et al. (2019). Drug delivery to tumours using a novel 5-FU derivative encapsulated into lipid nanocapsules. J. drug Target. 27, 634\u2013645. 10.1080/1061186x.2018.1547733", "ArticleIdList": ["10.1080/1061186x.2018.1547733", "30461322"]}, {"Citation": "Lu T. X., Rothenberg M. E. (2018). MicroRNA. J. allergy Clin. Immunol. 141, 1202\u20131207. 10.1016/j.jaci.2017.08.034", "ArticleIdList": ["10.1016/j.jaci.2017.08.034", "PMC5889965", "29074454"]}, {"Citation": "Meerloo J. V., Kaspers G. J., Cloos J. (2011). Cell sensitivity assays: the MTT assay, cancer cell culture. Germany: Springer, 237\u2013245.", "ArticleIdList": ["21516412"]}, {"Citation": "Men W., Zhu P., Dong S., Liu W., Zhou K., Bai Y., et al. (2020). Layer-by-layer pH-sensitive nanoparticles for drug delivery and controlled release with improved therapeutic efficacy in vivo . Drug Deliv. 27, 180\u2013190. 10.1080/10717544.2019.1709922", "ArticleIdList": ["10.1080/10717544.2019.1709922", "PMC7008239", "31924103"]}, {"Citation": "Mirhosseini M., Shekari-Far A., Hakimian F., Haghiralsadat B. F., Fatemi S. K., Dashtestani F. (2020). Core-shell Au@ Co-Fe hybrid nanoparticles as peroxidase mimetic nanozyme for antibacterial application. Process Biochem. 95, 131\u2013138. 10.1016/j.procbio.2020.05.003", "ArticleIdList": ["10.1016/j.procbio.2020.05.003"]}, {"Citation": "Nakayama M., Oshima M. (2019). Mutant p53 in colon cancer. J. Mol. Cell Biol. 11, 267\u2013276. 10.1093/jmcb/mjy075", "ArticleIdList": ["10.1093/jmcb/mjy075", "PMC6487790", "30496442"]}, {"Citation": "Oroojalian F., Rezayan A. H., Shier W. T., Abnous K., Ramezani M. (2017). Megalin-targeted enhanced transfection efficiency in cultured human HK-2 renal tubular proximal cells using aminoglycoside-carboxyalkyl-polyethylenimine-containing nanoplexes. Int. J. Pharm. 523, 102\u2013120. 10.1016/j.ijpharm.2017.03.024", "ArticleIdList": ["10.1016/j.ijpharm.2017.03.024", "28323095"]}, {"Citation": "Porru M., Pompili L., Caruso C., Biroccio A., Leonetti C. (2018). Targeting KRAS in metastatic colorectal cancer: current strategies and emerging opportunities. J. Exp. Clin. Cancer Res. 37, 57\u201310. 10.1186/s13046-018-0719-1", "ArticleIdList": ["10.1186/s13046-018-0719-1", "PMC5850913", "29534749"]}, {"Citation": "Pourpirali R., Mahmoudnezhad A., Oroojalian F., Zarghami N., Pilehvar Y. (2021). Prolonged proliferation and delayed senescence of the adipose-derived stem cells grown on the electrospun composite nanofiber co-encapsulated with TiO2 nanoparticles and metformin-loaded mesoporous silica nanoparticles. Int. J. Pharm. 604, 120733. 10.1016/j.ijpharm.2021.120733", "ArticleIdList": ["10.1016/j.ijpharm.2021.120733", "34044059"]}, {"Citation": "Spartalis C., Schmidt E. M., Elmasry M., Schulz G. B., Kirchner T., Horst D. (2019). In vivo effects of chemotherapy on oncogenic pathways in colorectal cancer. Cancer Sci. 110, 2529\u20132539. 10.1111/cas.14077", "ArticleIdList": ["10.1111/cas.14077", "PMC6676136", "31119819"]}, {"Citation": "Strand M. S., Krasnick B. A., Pan H., Zhang X., Bi Y., Brooks C., et al. (2019). Precision delivery of RAS-inhibiting siRNA to KRAS driven cancer via peptide-based nanoparticles. Oncotarget 10, 4761\u20134775. 10.18632/oncotarget.27109", "ArticleIdList": ["10.18632/oncotarget.27109", "PMC6677667", "31413817"]}, {"Citation": "Sung H., Ferlay J., Siegel R. L., Laversanne M., Soerjomataram I., Jemal A., et al. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca. A Cancer J. Clin. 71, 209\u2013249. 10.3322/caac.21660", "ArticleIdList": ["10.3322/caac.21660", "33538338"]}, {"Citation": "van Noort V., Sch\u00f6lch S., Iskar M., Zeller G., Ostertag K., Schweitzer C., et al. (2014). Novel drug candidates for the treatment of metastatic colorectal cancer through global inverse gene-expression profiling. Cancer Res. 74, 5690\u20135699. 10.1158/0008-5472.can-13-3540", "ArticleIdList": ["10.1158/0008-5472.can-13-3540", "25038229"]}, {"Citation": "Vodenkova S., Buchler T., Cervena K., Veskrnova V., Vodicka P., Vymetalkova V. (2020). 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future. Pharmacol. Ther. 206, 107447. 10.1016/j.pharmthera.2019.107447", "ArticleIdList": ["10.1016/j.pharmthera.2019.107447", "31756363"]}, {"Citation": "Xie Y., Wang Y., Li J., Hang Y., Jaramillo L., Wehrkamp C. J., et al. (2018). Cholangiocarcinoma therapy with nanoparticles that combine downregulation of MicroRNA-210 with inhibition of cancer cell invasiveness. Theranostics 8, 4305\u20134320. 10.7150/thno.26506", "ArticleIdList": ["10.7150/thno.26506", "PMC6134930", "30214622"]}, {"Citation": "Xie Y.-H., Chen Y.-X., Fang J.-Y. (2020). Comprehensive review of targeted therapy for colorectal cancer. Signal Transduct. Target. Ther. 5, 22\u201330. 10.1038/s41392-020-0116-z", "ArticleIdList": ["10.1038/s41392-020-0116-z", "PMC7082344", "32296018"]}, {"Citation": "Ye J., Lin M., Zhang C., Zhu X., Li S., Liu H., et al. (2020). Tissue gene mutation profiles in patients with colorectal cancer and their clinical implications. Biomed. Rep. 13, 43\u201348. 10.3892/br.2020.1303", "ArticleIdList": ["10.3892/br.2020.1303", "PMC7238404", "32440349"]}, {"Citation": "Yu Q., Xiong X., Zhao L., Xu T., Wang Q. (2020). Antifibrotic effects of specific siRNA targeting connective tissue growth factor delivered by polyethyleneimine-functionalized magnetic iron oxide nanoparticles on LX-2 cells. Mol. Med. Rep. 21, 181\u2013190. 10.3892/mmr.2019.10834", "ArticleIdList": ["10.3892/mmr.2019.10834", "PMC6896301", "31746398"]}, {"Citation": "Zhang Y., Xiong G. M., Ali Y., Boehm B. O., Huang Y. Y., Venkatraman S. (2021). Layer-by-layer coated nanoliposomes for oral delivery of insulin. Nanoscale 13, 776\u2013789. 10.1039/d0nr06104b", "ArticleIdList": ["10.1039/d0nr06104b", "33295926"]}, {"Citation": "Zhao Y.-C., Zhang L., Feng S.-S., Hong L., Zheng H.-L., Chen L.-L., et al. (2016). Efficient delivery of Notch1 siRNA to SKOV3 cells by cationic cholesterol derivative-based liposome. Int. J. Nanomedicine 11, 5485\u20135496. 10.2147/ijn.s115367", "ArticleIdList": ["10.2147/ijn.s115367", "PMC5077131", "27799771"]}, {"Citation": "Zhao J., Wan Z., Zhou C., Yang Q., Dong J., Song X., et al. (2018). Hyaluronic acid layer-by-layer (LbL) nanoparticles for synergistic chemo-phototherapy. Pharm. Res. 35, 196\u2013214. 10.1007/s11095-018-2480-8", "ArticleIdList": ["10.1007/s11095-018-2480-8", "30143878"]}, {"Citation": "Zook J. M., MacCuspie R. I., Locascio L. E., Halter M. D., Elliott J. T. (2011). Stable nanoparticle aggregates/agglomerates of different sizes and the effect of their size on hemolytic cytotoxicity. Nanotoxicology 5, 517\u2013530. 10.3109/17435390.2010.536615", "ArticleIdList": ["10.3109/17435390.2010.536615", "21142841"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "8", "Day": "7"}, {"Year": "2022", "Month": "9", "Day": "22"}, {"Year": "2022", "Month": "11", "Day": "3", "Hour": "2", "Minute": "37"}, {"Year": "2022", "Month": "11", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "11", "Day": "4", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["36324898", "PMC9618699", "10.3389/fbioe.2022.1013541", "1013541"]}}], "PubmedBookArticle": []}